Tags : Mild

Lupin and SunPharma Launch Generic Favipiravir to Treat Mild to

Shots: Lupin has launched favipiravir in India under the brand name ‘Covihalt’ for the treatment of mild to moderate COVID-19 Covihalt will be available as 200mg tablets in the form of a strip of 10 tablets, priced at $0.65 (₹49/tablet) and has received DCGI authorization for emergency use Additionally, SunPharma has launched antiviral drug favipiravir […]Read More

Glenmark Launches FabiFlu (favipiravir) as the First Oral Medication to

Shots: Glenmark has received manufacturing and marketing approval for its antiviral drug FabiFlu (favipiravir) to treat COVID-19 in India. The drug will be available as a prescribed therapy for INR 103/tablet with recommended dose being 1800mg (bid) on day 1, followed by 800mg (bid) up to day 14 Favipiravir demonstrated clinical improvements of up to […]Read More